Phase Forward to Present at the Raymond James 31st Annual Institutional Investors Conference
March 02 2010 - 4:05PM
Business Wire
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of
data management solutions for clinical trials and drug safety,
today announced its chairman and chief executive officer, Bob
Weiler, and senior vice president and chief financial officer,
Chris Menard, will present at the Raymond James 31st Annual
Institutional Investors Conference at the JW Marriott Grande Lakes
Hotel in Orlando, Florida.
The Phase Forward presentation is scheduled for Tuesday, March
9, 2010 at 4:35 p.m. ET. The presentation will be webcast live and
will be available by visiting the Investors section of the
company’s website at www.phaseforward.com. The webcast will be
archived on the company’s website for 30 days after the conference
ends.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward's products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 300 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2023 to Jul 2024